The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category

Affiliations

• ¹ Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.
• ² CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
• ³ St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
• ⁴ Austrian Academy of Sciences, CeMM Research Center for Molecular Medicine, Vienna, Austria.
• ⁵ Hematology Division, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
• ⁶ Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
• ⁷ Bristol Genetics Laboratory, Southmead Hospital, Bristol, UK.
• ⁸ Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
• ⁹ German Cancer Consortium (DKTK), and German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ¹⁰ Hematology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
• ¹¹ Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
• ¹² Department of Hematology, University Hospital, Zürich, Switzerland.
• ¹³ Department of Immunology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
• ¹⁴ Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany. [email protected].